Experimental virus vaccine takes on multiple cancers in early trial
Disease control
Recruiting now
This early-phase trial is testing a new virus-based cancer vaccine (PeptiCRAd-1) combined with the immunotherapy drug pembrolizumab in 15 people with various solid tumors like melanoma, triple-negative breast cancer, and lung cancer. The main goal is to see if the combination is …
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC